{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:33:48Z","timestamp":1788150828963,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,3]]},"DOI":"10.7759\/cureus.100675","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T12:45:34Z","timestamp":1767444334000},"source":"Crossref","is-referenced-by-count":2,"title":["Management of Complications Following Botulinum Toxin Facial Injections: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Sara","family":"Freixo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Cam\u00f5es-Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Use of botulinum neurotoxin in ophthalmology","volume":"46","author":"Ba\u015far E","year":"2016","unstructured":"Ba\u015far E, Ar\u0131c\u0131 C. Use of botulinum neurotoxin in ophthalmology. Turk J Ophthalmol. 2016, 46:282-90.","journal-title":"Turk J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.03.013","article-title":"Chemodenervation for the treatment of facial dystonia: a report by the American Academy of Ophthalmology","volume":"125","author":"Bilyk JR","year":"2018","unstructured":"Bilyk JR, Yen MT, Bradley EA, Wladis EJ, Mawn LA. Chemodenervation for the treatment of facial dystonia: a report by the American Academy of Ophthalmology. Ophthalmology. 2018, 125:1459-67. 10.1016\/j.ophtha.2018.03.013","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48493","article-title":"Shoulder spasticity treatment with botulinum toxin: a nationwide cross-sectional survey of clinical practices","volume":"15","author":"Pinho S","year":"2023","unstructured":"Pinho S, Cam\u00f5es-Barbosa A, Hatia M, Moeda F, Melo X, Tocha J. Shoulder spasticity treatment with botulinum toxin: a nationwide cross-sectional survey of clinical practices. Cureus. 2023, 15:e48493. 10.7759\/cureus.48493","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jormas.2024.101804","article-title":"IncobotulinumtoxinA in refractory temporomandibular disorder due to disk dislocation: a prospective study","volume":"125","author":"Ferreira EF","year":"2024","unstructured":"Ferreira EF, Cam\u00f5es-Barbosa A. IncobotulinumtoxinA in refractory temporomandibular disorder due to disk dislocation: a prospective study. J Stomatol Oral Maxillofac Surg. 2024, 125:101804. 10.1016\/j.jormas.2024.101804","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73389","article-title":"Botulinum toxin type A in trigeminal neuralgia treatment: a case series and literature review","volume":"16","author":"Santos RF","year":"2024","unstructured":"Santos RF, Machado M, Ferro M, Cam\u00f5es-Barbosa A. Botulinum toxin type A in trigeminal neuralgia treatment: a case series and literature review. Cureus. 2024, 16:e73389. 10.7759\/cureus.73389","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v11i5.3590","article-title":"Efficacy of incobotulinumtoxinA for spasticity-associated pain in a series of patients with spasticity of diverse etiologies","volume":"11","author":"Camoes-Barbosa A","year":"2023","unstructured":"Camoes-Barbosa A. Efficacy of incobotulinumtoxinA for spasticity-associated pain in a series of patients with spasticity of diverse etiologies. Med Res Arch. 2023, 11:1-13. 10.18103\/mra.v11i5.3590","journal-title":"Med Res Arch"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2022\/52959.15957","article-title":"Botulinum neurotoxin injection as a therapeutic option in thoracic outlet syndrome caused by a supernumerary scalenus muscle: a case report","volume":"16","author":"Freitas MM","year":"2022","unstructured":"Freitas MM, Barbosa AC. Botulinum neurotoxin injection as a therapeutic option in thoracic outlet syndrome caused by a supernumerary scalenus muscle: a case report. J Clin Diagn Res. 2022, 16: KD01-3. 10.7860\/jcdr\/2022\/52959.15957","journal-title":"J Clin Diagn Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13120887","article-title":"Pain reduction in adults with limb spasticity following treatment with incobotulinumtoxina: a pooled analysis","volume":"13","author":"Wissel J","year":"2021","unstructured":"Wissel J, Cam\u00f5es-Barbosa A, Comes G, Althaus M, Scheschonka A, Simpson DM. Pain reduction in adults with limb spasticity following treatment with incobotulinumtoxina: a pooled analysis. Toxins (Basel). 2021, 13:887. 10.3390\/toxins13120887","journal-title":"Toxins (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MRR.0000000000000495","article-title":"Botulinum toxin type A therapy for bilateral focal neuropathic pruritus in multiple sclerosis: a case report","volume":"44","author":"Portugal DM","year":"2021","unstructured":"Portugal DM, Ferreira EF, Cam\u00f5es-Barbosa A. Botulinum toxin type A therapy for bilateral focal neuropathic pruritus in multiple sclerosis: a case report. Int J Rehabil Res. 2021, 44:382-3. 10.1097\/MRR.0000000000000495","journal-title":"Int J Rehabil Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13273","article-title":"Facial aesthetic injections in clinical practice: pretreatment and posttreatment consensus recommendations to minimise adverse outcomes","volume":"61","author":"Goodman GJ","year":"2020","unstructured":"Goodman GJ, Liew S, Callan P, Hart S. Facial aesthetic injections in clinical practice: pretreatment and posttreatment consensus recommendations to minimise adverse outcomes. Australas J Dermatol. 2020, 61:217-25. 10.1111\/ajd.13273","journal-title":"Australas J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1298786","article-title":"Botulinum toxin: clinical techniques, applications, and complications","volume":"27","author":"Stephan S","year":"2011","unstructured":"Stephan S, Wang TD. Botulinum toxin: clinical techniques, applications, and complications. Facial Plast Surg. 2011, 27:529-39. 10.1055\/s-0031-1298786","journal-title":"Facial Plast Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13266","article-title":"Complications of botulinum toxin and fillers: a narrative review","volume":"19","author":"Kassir M","year":"2020","unstructured":"Kassir M, Gupta M, Galadari H, et al.. Complications of botulinum toxin and fillers: a narrative review. J Cosmet Dermatol. 2020, 19:570-3. 10.1111\/jocd.13266","journal-title":"J Cosmet Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjac036","article-title":"Complications of cosmetic botulinum toxin A injections to the upper face: a systematic review and meta-analysis","volume":"42","author":"Zargaran D","year":"2022","unstructured":"Zargaran D, Zoller F, Zargaran A, Rahman E, Woollard A, Weyrich T, Mosahebi A. Complications of cosmetic botulinum toxin A injections to the upper face: a systematic review and meta-analysis. Aesthet Surg J. 2022, 42:NP327-36. 10.1093\/asj\/sjac036","journal-title":"Aesthet Surg J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.20344\/amp.11503","article-title":"Contralateral upper limb weakness following botulinum toxin A injection for poststroke spasticity","volume":"33","author":"Cam\u00f5es-Barbosa A","year":"2020","unstructured":"Cam\u00f5es-Barbosa A, Ribeiro IM, Medeiros L. Contralateral upper limb weakness following botulinum toxin A injection for poststroke spasticity. Acta Med Port. 2020, 33:761-4. 10.20344\/amp.11503","journal-title":"Acta Med Port"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/geriatrics10060155","article-title":"Efficacy and safety of incobotulinumtoxinA in older patients with upper limb spasticity: a pooled analysis","volume":"10","author":"Munin MC","year":"2025","unstructured":"Munin MC, Cam\u00f5es-Barbosa A, Cordero-Garc\u00eda C, et al.. Efficacy and safety of incobotulinumtoxinA in older patients with upper limb spasticity: a pooled analysis. Geriatrics (Basel). 2025, 10:155. 10.3390\/geriatrics10060155","journal-title":"Geriatrics (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14160","article-title":"Complications of botulinum toxin A: an update review","volume":"20","author":"Kroumpouzos G","year":"2021","unstructured":"Kroumpouzos G, Kassir M, Gupta M, Patil A, Goldust M. Complications of botulinum toxin A: an update review. J Cosmet Dermatol. 2021, 20:1585-90. 10.1111\/jocd.14160","journal-title":"J Cosmet Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2020.02.016","article-title":"What are the most commonly reported complications with cosmetic botulinum toxin type A treatments?","volume":"78","author":"Lee KC","year":"2020","unstructured":"Lee KC, Pascal AB, Halepas S, Koch A. What are the most commonly reported complications with cosmetic botulinum toxin type A treatments?. J Oral Maxillofac Surg. 2020, 78:1190.e1-9. 10.1016\/j.joms.2020.02.016","journal-title":"J Oral Maxillofac Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2003.12.026","article-title":"Contraindications and complications with the use of botulinum toxin","volume":"22","author":"Klein AW","year":"2004","unstructured":"Klein AW. Contraindications and complications with the use of botulinum toxin. Clin Dermatol. 2004, 22:66-75. 10.1016\/j.clindermatol.2003.12.026","journal-title":"Clin Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-004-0031-7","article-title":"Complications with the use of botulinum toxin type A in facial rejuvenation: report of 8 cases","volume":"28","author":"Ferreira MC","year":"2004","unstructured":"Ferreira MC, Salles AG, Gimenez R, Soares MF. Complications with the use of botulinum toxin type A in facial rejuvenation: report of 8 cases. Aesthetic Plast Surg. 2004, 28:441-4. 10.1007\/s00266-004-0031-7","journal-title":"Aesthetic Plast Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14279","article-title":"Ophthalmic adverse events following facial injections of botulinum toxin A: a systemic literature review","volume":"20","author":"Skorochod R","year":"2021","unstructured":"Skorochod R, Nesher R, Nesher G, Gronovich Y. Ophthalmic adverse events following facial injections of botulinum toxin A: a systemic literature review. J Cosmet Dermatol. 2021, 20:2409-13. 10.1111\/jocd.14279","journal-title":"J Cosmet Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/joms.2003.50069","article-title":"Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments","volume":"61","author":"Niamtu J 3rd","year":"2003","unstructured":"Niamtu J 3rd. Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments. J Oral Maxillofac Surg. 2003, 61:317-24. 10.1053\/joms.2003.50069","journal-title":"J Oral Maxillofac Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsc.2013.07.002","article-title":"Lasers, fillers, and neurotoxins: avoiding complications in the cosmetic facial practice","volume":"21","author":"Hassouneh B","year":"2013","unstructured":"Hassouneh B, Newman JP. Lasers, fillers, and neurotoxins: avoiding complications in the cosmetic facial practice. Facial Plast Surg Clin North Am. 2013, 21:585-98. 10.1016\/j.fsc.2013.07.002","journal-title":"Facial Plast Surg Clin North Am"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1312695","article-title":"Facial filler and neurotoxin complications","volume":"28","author":"Nettar K","year":"2012","unstructured":"Nettar K, Maas C. Facial filler and neurotoxin complications. Facial Plast Surg. 2012, 28:288-93. 10.1055\/s-0032-1312695","journal-title":"Facial Plast Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-16362","article-title":"Botulinum A exotoxin for rejuvenation of the upper third of the face","volume":"17","author":"Carucci JA","year":"2001","unstructured":"Carucci JA, Zweibel SM. Botulinum A exotoxin for rejuvenation of the upper third of the face. Facial Plast Surg. 2001, 17:11-20. 10.1055\/s-2001-16362","journal-title":"Facial Plast Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsc.2004.04.008","article-title":"Complications of botulinum toxin A use in facial rejuvenation","volume":"13","author":"Vartanian AJ","year":"2005","unstructured":"Vartanian AJ, Dayan SH. Complications of botulinum toxin A use in facial rejuvenation. Facial Plast Surg Clin North Am. 2005, 13:1-10. 10.1016\/j.fsc.2004.04.008","journal-title":"Facial Plast Surg Clin North Am"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1155\/drp\/8827594","article-title":"Iatrogenic blepharoptosis: multimodal management and treatment technique with botulinum toxin type A","volume":"2025","author":"Jaime Alberto RP","year":"2025","unstructured":"Jaime Alberto RP, Paola Andrea MA, Maria Paulina UP, Luisa LB. Iatrogenic blepharoptosis: multimodal management and treatment technique with botulinum toxin type A. Dermatol Res Pract. 2025, 2025:8827594. 10.1155\/drp\/8827594","journal-title":"Dermatol Res Pract"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.104667","article-title":"Upper face rejuvenation using botulinum toxin and hyaluronic acid fillers","volume":"79","author":"Nanda S","year":"2013","unstructured":"Nanda S, Bansal S. Upper face rejuvenation using botulinum toxin and hyaluronic acid fillers. Indian J Dermatol Venereol Leprol. 2013, 79:32-40. 10.4103\/0378-6323.104667","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/wjo2.121","article-title":"Office-based facial plastics procedures: neuromodulators","volume":"9","author":"Johnson AJ","year":"2023","unstructured":"Johnson AJ, Chen DS. Office-based facial plastics procedures: neuromodulators. World J Otorhinolaryngol Head Neck Surg. 2023, 9:220-6. 10.1002\/wjo2.121","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2021.04.009","article-title":"Complications and adverse effects of periocular aesthetic treatments","volume":"67","author":"Nagendran ST","year":"2022","unstructured":"Nagendran ST, Ali MJ, Dogru M, Malhotra R. Complications and adverse effects of periocular aesthetic treatments. Surv Ophthalmol. 2022, 67:741-57. 10.1016\/j.survophthal.2021.04.009","journal-title":"Surv Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27492012000300014","article-title":"Botox\u00ae after Botox\u00ae - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports","volume":"75","author":"Isaac CR","year":"2012","unstructured":"Isaac CR, Chalita MR, Pinto LD. Botox\u00ae after Botox\u00ae - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports. Arq Bras Oftalmol. 2012, 75:213-4. 10.1590\/s0004-27492012000300014","journal-title":"Arq Bras Oftalmol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2002.01149.x","article-title":"Decreased tear expression with an abnormal Schirmer's test following botulinum toxin type A for the treatment of lateral canthal rhytides","volume":"28","author":"Matarasso SL","year":"2002","unstructured":"Matarasso SL. Decreased tear expression with an abnormal Schirmer's test following botulinum toxin type A for the treatment of lateral canthal rhytides. Dermatol Surg. 2002, 28:149-52. 10.1046\/j.1524-4725.2002.01149.x","journal-title":"Dermatol Surg"},{"key":"ref32","article-title":"Botulinum toxin injection for facial wrinkles","volume":"90","author":"Small R","year":"2014","unstructured":"Small R. Botulinum toxin injection for facial wrinkles. Am Fam Physician. 2014, 90:168-75.","journal-title":"Am Fam Physician"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-020-02027-z","article-title":"Adverse events associated with Botox as reported in a Food and Drug Administration database","volume":"45","author":"Ahsanuddin S","year":"2021","unstructured":"Ahsanuddin S, Roy S, Nasser W, Povolotskiy R, Paskhover B. Adverse events associated with Botox as reported in a Food and Drug Administration database. Aesthetic Plast Surg. 2021, 45:1201-9. 10.1007\/s00266-020-02027-z","journal-title":"Aesthetic Plast Surg"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2174\/0127724328310459240809073519","article-title":"Anatomy, etiology, management, and medico-legal implications of botulinum-induced blepharoptosis","volume":"20","author":"Nittari G","year":"2025","unstructured":"Nittari G, Savva D, Gibelli F, Vulcanescu D, De Leo D, Ricci G. Anatomy, etiology, management, and medico-legal implications of botulinum-induced blepharoptosis. Curr Rev Clin Exp Pharmacol. 2025, 20:32-7. 10.2174\/0127724328310459240809073519","journal-title":"Curr Rev Clin Exp Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S306155","article-title":"Rapid and sustained eyelid elevation in acquired blepharoptosis with oxymetazoline 0.1%: randomized phase 3 trial results","volume":"15","author":"Bacharach J","year":"2021","unstructured":"Bacharach J, Wirta DL, Smyth-Medina R, et al.. Rapid and sustained eyelid elevation in acquired blepharoptosis with oxymetazoline 0.1%: randomized phase 3 trial results. Clin Ophthalmol. 2021, 15:2743-51. 10.2147\/OPTH.S306155","journal-title":"Clin Ophthalmol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14361","article-title":"Botulinum toxin-induced blepharoptosis: anatomy, etiology, prevention, and therapeutic options","volume":"20","author":"Nestor MS","year":"2021","unstructured":"Nestor MS, Han H, Gade A, Fischer D, Saban Y, Polselli R. Botulinum toxin-induced blepharoptosis: anatomy, etiology, prevention, and therapeutic options. J Cosmet Dermatol. 2021, 20:3133-46. 10.1111\/jocd.14361","journal-title":"J Cosmet Dermatol"},{"key":"ref37","article-title":"Use of botulinum toxin for the correction of mild ptosis","volume":"11","author":"Mustak H","year":"2018","unstructured":"Mustak H, Rafaelof M, Goldberg RA, Rootman D. Use of botulinum toxin for the correction of mild ptosis. J Clin Aesthet Dermatol. 2018, 11:49-51.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjad070","article-title":"Management of severe botulinum-induced eyelid ptosis with pretarsal botulinum toxin and oxymetazoline hydrochloride 0.1%","volume":"43","author":"Bernardini FP","year":"2023","unstructured":"Bernardini FP, Skippen B, Croasdell B, et al.. Management of severe botulinum-induced eyelid ptosis with pretarsal botulinum toxin and oxymetazoline hydrochloride 0.1%. Aesthet Surg J. 2023, 43:955-61. 10.1093\/asj\/sjad070","journal-title":"Aesthet Surg J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41246","article-title":"Ophthalmic complications of periorbital and facial aesthetic procedures: a literature review","volume":"15","author":"Alharbi MM","year":"2023","unstructured":"Alharbi MM, Bin Dlaim MS, Alqahtani JM, Alkhudhairy NS, Almasoudi SM, Alajmi NT. Ophthalmic complications of periorbital and facial aesthetic procedures: a literature review. Cureus. 2023, 15:e41246. 10.7759\/cureus.41246","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/449913-management-of-complications-following-botulinum-toxin-facial-injections-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T12:45:35Z","timestamp":1767444335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/449913-management-of-complications-following-botulinum-toxin-facial-injections-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.100675","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,3]]}}}